Composition for distinguishing pancreatic cancer and chronic pancreatitis, and uses thereof
A technology for chronic pancreatitis and composition, which is applied in the field of medical testing and can solve problems such as overdiagnosis, high false positives, and overtreatment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0069] Plasma samples from 19 patients with pancreatic cancer, 15 patients with chronic pancreatitis, and 16 normal subjects were obtained. All samples come from Boercheng Company. Pancreatic cancer, chronic pancreatitis, and normal human genomic DNA were then extracted, and the genomic DNA samples were pretreated so that unmethylated cytosine bases at the 5' position were converted to uracil, thymine, or Another base not used for cytosine in hybridization behavior. In this example, this pretreatment was achieved by bisulfite reagent treatment. The extraction and processing of the DNA can be carried out by any standard means in the prior art. Specifically, in this embodiment, all sample DNA extraction and bisulfite DNA modification are carried out by using Boercheng Company Extracted from the plasma processing kit. Then, the above-mentioned BNC1 and ADAMTS1 gene primers, probe combinations and internal reference gene ACTB gene primers and probe combinations were added to th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com